$CBAY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CymaBay Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CymaBay Therapeutics, Inc.. Get notifications about new insider transactions in CymaBay Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | CBAY | CymaBay Therapeuti ... | STUART LEWIS J | Chief Commercial Of ... | Option Exercise | A | 3.94 | 360,000 | 1,418,400 | 360,000 | |
Apr 05 2021 | CBAY | CymaBay Therapeuti ... | WIGGANS THOMAS G | Director | Option Exercise | A | 4.63 | 80,000 | 370,400 | 80,000 | |
Feb 01 2021 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 5.78 | 32,000 | 184,960 | 32,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 5.78 | 32,000 | 184,960 | 32,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 5.78 | 32,000 | 184,960 | 32,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Loewy Caroline M | Director | Option Exercise | A | 5.78 | 32,000 | 184,960 | 32,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Option Exercise | A | 5.78 | 42,000 | 242,760 | 42,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 5.78 | 66,500 | 384,370 | 66,500 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | McWherter Charles | Chief Scientific Of ... | Option Exercise | A | 5.78 | 112,000 | 647,360 | 112,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Option Exercise | A | 5.78 | 287,000 | 1,658,860 | 287,000 | |
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Quinlan Paul T | General Counsel | Option Exercise | A | 5.78 | 22,167 | 128,125 | 22,167 | |
Oct 14 2020 | CBAY | CymaBay Therapeuti ... | Quinlan Paul T | General Counsel | Option Exercise | A | 7.89 | 275,000 | 2,169,750 | 275,000 | |
Jun 23 2020 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | von Emster Kurt | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | Loewy Caroline M | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 4.05 | 49,245 | 199,442 | 49,245 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Option Exercise | A | 4.05 | 180,564 | 731,284 | 180,564 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | See Remarks | Option Exercise | A | 4.05 | 328,299 | 1,329,611 | 328,299 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Option Exercise | A | 4.05 | 328,299 | 1,329,611 | 328,299 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | Shah Sujal | President & CEO | Option Exercise | A | 4.05 | 558,108 | 2,260,337 | 558,108 | |
Oct 15 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 4.30 | 5,000 | 21,500 | 120,000 | 115 K to 120 K (+4.35 %) |
Sep 24 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 5.55 | 3,100 | 17,205 | 115,000 | 111.9 K to 115 K (+2.77 %) |
Sep 24 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 5.50 | 1,900 | 10,450 | 111,900 | 110 K to 111.9 K (+1.73 %) |
Aug 05 2019 | CBAY | CymaBay Therapeuti ... | Dorling Janet | Chief Commercial Of ... | Option Exercise | A | 5.64 | 341,000 | 1,923,240 | 341,000 | |
Feb 08 2019 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 5.50 | 9,340 | 51,370 | 0 | |
Feb 08 2019 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 5.00 | 2,335 | 11,675 | 0 | |
Feb 08 2019 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Sell | S | 9.02 | 11,675 | 105,328 | 0 | 11.7 K to 0 (-100.00 %) |
Feb 08 2019 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Buy | M | 5.50 | 9,340 | 51,370 | 11,675 | 2.3 K to 11.7 K (+400.00 %) |
Feb 08 2019 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Buy | M | 5.00 | 2,335 | 11,675 | 2,335 | 0 to 2.3 K |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Option Exercise | A | 8.43 | 69,156 | 582,985 | 69,156 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 8.43 | 138,312 | 1,165,970 | 138,312 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Quinlan Paul T | General Counsel | Option Exercise | A | 8.43 | 86,445 | 728,731 | 86,445 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 8.43 | 138,312 | 1,165,970 | 138,312 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | McWherter Charles | Chief Science Offic ... | Option Exercise | A | 8.43 | 172,891 | 1,457,471 | 172,891 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Option Exercise | A | 8.43 | 328,492 | 2,769,188 | 328,492 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | STEIN EVAN A. | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Loewy Caroline M | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Booth Robert F. | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Dec 21 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 6.54 | 10,000 | 65,399 | 110,000 | 100 K to 110 K (+10.00 %) |
Dec 19 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 7.43 | 53,492 | 397,365 | 131,036 | 184.5 K to 131 K (-28.99 %) |
Dec 19 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 8.17 | 88,889 | 726,223 | 184,528 | 273.4 K to 184.5 K (-32.51 %) |
Oct 16 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 9.90 | 5,000 | 49,500 | 100,000 | 95 K to 100 K (+5.26 %) |
Aug 31 2018 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Option Exercise | M | 5.00 | 5,000 | 25,000 | 14,459 | |
Aug 31 2018 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Sell | S | 13.00 | 5,000 | 65,000 | 0 | 5 K to 0 (-100.00 %) |
Aug 31 2018 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Buy | M | 5.00 | 5,000 | 25,000 | 5,000 | 0 to 5 K |
Jul 30 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 10.90 | 5,000 | 54,500 | 95,000 | 90 K to 95 K (+5.56 %) |
Jun 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | X | 5.75 | 2,000 | 11,500 | 0 | |
Jun 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.51 | 920 | 11,509 | 18,316 | 19.2 K to 18.3 K (-4.78 %) |
Jun 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | X | 5.75 | 2,000 | 11,500 | 19,236 | 21.2 K to 19.2 K (-9.42 %) |
May 15 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Buy | P | 10.65 | 5,000 | 53,250 | 90,000 | 85 K to 90 K (+5.88 %) |
Mar 23 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 5.50 | 5,660 | 31,130 | 9,340 | |
Mar 23 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 5.00 | 2,870 | 14,350 | 0 | |
Mar 23 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 5.00 | 6,470 | 32,350 | 0 | |
Mar 23 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Sell | S | 13.03 | 15,000 | 195,375 | 0 | 15 K to 0 (-100.00 %) |
Mar 23 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Buy | M | 5.50 | 5,660 | 31,130 | 15,000 | 9.3 K to 15 K (+60.60 %) |
Mar 23 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Buy | M | 5.00 | 9,340 | 46,700 | 9,340 | 0 to 9.3 K |
Mar 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 15.51 | 13,353 | 207,105 | 273,417 | 286.8 K to 273.4 K (-4.66 %) |
Feb 20 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 14.49 | 68,712 | 995,637 | 286,770 | 355.5 K to 286.8 K (-19.33 %) |
Feb 15 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 16.69 | 162,979 | 2,720,120 | 355,482 | 518.5 K to 355.5 K (-31.44 %) |
Feb 15 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 13.51 | 55,078 | 744,104 | 518,461 | 573.5 K to 518.5 K (-9.60 %) |
Feb 12 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Buy | P | 6.50 | 153,846 | 999,999 | 1,753,846 | 1.6 M to 1.8 M (+9.62 %) |
Feb 07 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.14 | 18,831 | 228,608 | 460,456 | 479.3 K to 460.5 K (-3.93 %) |
Feb 01 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.23 | 12,300 | 150,429 | 569,385 | 581.7 K to 569.4 K (-2.11 %) |
Feb 01 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.22 | 85,339 | 1,042,843 | 581,685 | 667 K to 581.7 K (-12.79 %) |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.18 | 39,438 | 480,355 | 667,024 | 706.5 K to 667 K (-5.58 %) |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 12.18 | 39,438 | 480,355 | 667,024 | 706.5 K to 667 K (-5.58 %) |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Executive Off ... | Option Exercise | A | 11.69 | 150,000 | 1,753,500 | 150,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | OMara Patrick J. | SVP, Business Devel ... | Option Exercise | A | 11.69 | 125,000 | 1,461,250 | 125,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Option Exercise | A | 11.69 | 62,500 | 730,625 | 62,500 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | McWherter Charles | Chief Science Offic ... | Option Exercise | A | 11.69 | 150,000 | 1,753,500 | 150,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Quinlan Paul T | General Counsel | Option Exercise | A | 11.69 | 50,000 | 584,500 | 50,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Quinlan Paul T | General Counsel | Option Exercise | A | 11.69 | 250,000 | 2,922,500 | 250,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Martin Robert L. | SVP, Nonclinical & ... | Option Exercise | A | 11.69 | 125,000 | 1,461,250 | 125,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 11.69 | 125,000 | 1,461,250 | 125,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | SVP, Regulatory and ... | Option Exercise | A | 11.69 | 100,000 | 1,169,000 | 100,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | STEIN EVAN A. | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Loewy Caroline M | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Booth Robert F. | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Jan 24 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.40 | 138,253 | 1,437,831 | 706,462 | 844.7 K to 706.5 K (-16.37 %) |
Jan 22 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.25 | 130,584 | 1,338,486 | 844,715 | 975.3 K to 844.7 K (-13.39 %) |
Jan 22 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.21 | 13,632 | 139,183 | 975,299 | 988.9 K to 975.3 K (-1.38 %) |
Jan 09 2018 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 10.21 | 4,300 | 43,903 | 988,931 | 993.2 K to 988.9 K (-0.43 %) |
Dec 27 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.41 | 173,192 | 1,629,304 | 993,231 | 1.2 M to 993.2 K (-14.85 %) |
Nov 14 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.26 | 50,048 | 463,379 | 1,166,423 | 1.2 M to 1.2 M (-4.11 %) |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 2.97 | 9,000 | 26,730 | 0 | |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | M | 1.72 | 9,000 | 15,480 | 0 | |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Sell | S | 8.66 | 18,000 | 155,880 | 0 | 18 K to 0 (-100.00 %) |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Buy | M | 2.97 | 9,000 | 26,730 | 18,000 | 9 K to 18 K (+100.00 %) |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Buy | M | 1.72 | 9,000 | 15,480 | 9,000 | 0 to 9 K |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Buy | P | 8.67 | 4,700 | 40,740 | 15,000 | 10.3 K to 15 K (+45.63 %) |
Nov 06 2017 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Buy | P | 8.67 | 300 | 2,601 | 10,300 | 10 K to 10.3 K (+3.00 %) |
Nov 03 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.25 | 4,320 | 39,979 | 1,216,471 | 1.2 M to 1.2 M (-0.35 %) |
Nov 01 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.27 | 52,573 | 487,352 | 1,220,791 | 1.3 M to 1.2 M (-4.13 %) |
Nov 01 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 9.26 | 6,636 | 61,449 | 1,273,364 | 1.3 M to 1.3 M (-0.52 %) |
Oct 31 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | President & CEO | Option Exercise | A | 9.21 | 640,000 | 5,894,400 | 640,000 | |
Oct 04 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 7.81 | 70,940 | 554,041 | 1,280,000 | 1.4 M to 1.3 M (-5.25 %) |
Oct 04 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 7.93 | 37,936 | 300,832 | 1,350,940 | 1.4 M to 1.4 M (-2.73 %) |
Oct 02 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 8.04 | 120,735 | 970,709 | 1,388,876 | 1.5 M to 1.4 M (-8.00 %) |
Oct 02 2017 | CBAY | CymaBay Therapeuti ... | EMSTER KURT VON | Director | Sell | S | 8.15 | 90,389 | 736,670 | 1,509,611 | 1.6 M to 1.5 M (-5.65 %) |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | von Emster Kurt | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | Loewy Caroline M | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | STEIN EVAN A. | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | Booth Robert F. | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Aug 02 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Buy | P | 6.85 | 3,500 | 23,965 | 30,000 | 26.5 K to 30 K (+13.21 %) |
Aug 02 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Buy | P | 6.84 | 1,000 | 6,839 | 26,500 | 25.5 K to 26.5 K (+3.92 %) |
Aug 02 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Buy | P | 6.84 | 300 | 2,051 | 25,500 | 25.2 K to 25.5 K (+1.19 %) |
Aug 02 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Buy | P | 6.83 | 200 | 1,366 | 25,200 | 25 K to 25.2 K (+0.80 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Buy | P | 7.43 | 1,700 | 12,629 | 10,000 | 8.3 K to 10 K (+20.48 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Buy | P | 7.43 | 200 | 1,486 | 8,300 | 8.1 K to 8.3 K (+2.47 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Buy | P | 7.43 | 3,000 | 22,280 | 8,100 | 5.1 K to 8.1 K (+58.82 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | McWherter Charles | SVP & Chief Scienti ... | Buy | P | 7.42 | 100 | 742 | 5,100 | 5 K to 5.1 K (+2.00 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.35 | 8,033 | 59,043 | 85,000 | 77 K to 85 K (+10.44 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.32 | 100 | 732 | 76,967 | 76.9 K to 77 K (+0.13 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.31 | 576 | 4,211 | 76,867 | 76.3 K to 76.9 K (+0.76 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.30 | 400 | 2,920 | 76,291 | 75.9 K to 76.3 K (+0.53 %) |
Jul 24 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim President & ... | Buy | P | 7.29 | 891 | 6,495 | 75,891 | 75 K to 75.9 K (+1.19 %) |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | GOLDFISCHER CARL | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Booth Robert F. | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Loewy Caroline M | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | STEIN EVAN A. | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | von Emster Kurt | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | SVP, Regulatory Aff ... | Option Exercise | A | 5.50 | 200,000 | 1,100,000 | 200,000 | |
May 05 2017 | CBAY | CymaBay Therapeuti ... | Menold Daniel | Vice President, Fin ... | Option Exercise | A | 3.45 | 35,000 | 120,750 | 35,000 | |
May 01 2017 | CBAY | CymaBay Therapeuti ... | Wills Robert James | Director | Option Exercise | A | 3.48 | 27,000 | 93,960 | 27,000 | |
May 01 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Interim CEO | Option Exercise | A | 3.48 | 90,000 | 313,200 | 90,000 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 1.72 | 12,000 | 20,640 | 12,000 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | Van Wart Harold | President and CEO | Option Exercise | A | 1.72 | 200,000 | 344,000 | 200,000 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | TRUEX PAUL F | Director | Option Exercise | A | 1.72 | 12,000 | 20,640 | 12,000 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | STEIN EVAN A. | Director | Option Exercise | A | 1.72 | 12,000 | 20,640 | 12,000 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | Shah Sujal | Chief Financial Off ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | Rosemark Kirk | V.P. Regulatory & Q ... | Option Exercise | A | 1.72 | 50,000 | 86,000 | 50,000 |